InvestorsHub Logo
Followers 85
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: biopharm post# 200803

Monday, 01/19/2015 1:57:12 PM

Monday, January 19, 2015 1:57:12 PM

Post# of 346183
Dmitry Gabrilovich : Peregrine Pharmaceuticals KOL :

Talk: Immunosuppressive mechanisms in myeloid cells (49 min)

http://hstalks.com/main/view_talk.php?t=2956&r=494&j=755&c=252

You need to sign up for a free trial and listen to the entire 49 min's because:

----------------

ABOUT THIS TALK

Speaker(s)
Prof. Dmitry Gabrilovich Show Biography

Publication Date
December, 2014

Topics Covered
Myeloid derived suppressor cells (MDSC) and their potent immune suppressive activity... more ** see below **

Series
Topical Talks

---------------

**TOPICS COVERED IN THIS TALK


Myeloid derived suppressor cells (MDSC) and their potent immune suppressive activity

MDSC in cancer

MDSC in chronic infections

MDSC during stress

MDSC in surgical trauma


The two main populations of MDSC: monocytic MDSC (M-MDSC) and polymorphonuclear MDSC (PMN-MDSC)

Biological differences between MDSC and their normal counterparts

Multiple mechanisms of expansion regulation and immune suppressive function of MDSC

MDSC role in antigen-specific T cell tolerance in tumor-bearing mice

Therapeutic regulation of MDSC in mice and humans



"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News